The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes
Abstract
Purpose: The aims of this study were to identify the most significant prognostic factors in myelodysplastic syndromes (MDS) taking into account both their values at clinical onset and their changes in time and to develop a dynamic model for predicting survival and leukemic evolution that can be applied at any time during the course of the disease. Patients and Methods: We studied a learning cohort of 426 MDS patients diagnosed at the Department of Hematology, San Matteo Hospital, Pavia, Italy, between 1992 and 2004, and a validation cohort of 739 patients diagnosed at the Heinrich-Heine-University Hospital, Düsseldorf, Germany, between 1982 and 2003. All patients were reclassified according to WHO criteria. Univariable and multivariable analyses were performed using Cox models with time-dependent covariates. Results: The most important variables for the prognostic model were WHO subgroups, karyotype, and transfusion requirement. We defined a WHO classification–based prognostic scoring system (WPSS) that was able to classify patients into five risk groups showing different survivals (median survival from 12 to 103 months) and probabilities of leukemic evolution (P < .001). WPSS was shown to predict survival and leukemia progression at any time during follow-up (P < .001), and its prognostic value was confirmed in the validation cohort. Conclusion: WPSS is a dynamic prognostic scoring system that provides an accurate prediction of survival and risk of leukemic evolution in MDS patients at any time during the course of their disease. This time-dependent system seems particularly useful in lower risk patients and may be used for implementing risk-adapted treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Self-citationProposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Malcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
Self-citationMyelodysplastic syndromes: a scoring system with prognostic significance
Mufti, G. J., Stevens, J. R., Oscier, D. G., Hamblin, T. J., & Machin, D. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07329.x · Cited by 507
Sanz, G., Sanz, M., Vallespi, T., Canizo, M., Torrabadella, M., Garcia, S., Irriguible, D., & San Miguel, J. (1989) · Blood · doi:10.1182/blood.v74.1.395.395 · Cited by 406
Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis
Cazzola, M., & Malcovati, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048266 · Cited by 343
Self-citationGuidelines for the diagnosis and therapy of adult myelodysplastic syndromes
Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D., Parker, J., & of the UK MDS Guidelines Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03907.x · Cited by 298
Germing, U., Gattermann, N., Strupp, C., Aivado, M., & Aul, C. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00088-6 · Cited by 296
Self-citationBone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.
Sierra, J., Pérez, W. S., Rozmán, C., Carreras, E., Klein, J. P., Rizzo, J. D., Davies, S. M., Lazarus, H. M., Bredeson, C., Marks, D. I., et al. (2002) · PubMed · Cited by 269
Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G., & Schneider, W. (1992) · PubMed · Cited by 265
Self-citationSolé, F. G., Luño, E., Sanzo, C., Espinet, B., Sanz, G. F., Cervera, J., Calasanz, M. J., Cigudosa, J. C., Millá, F., Ribera, J., et al. (2005) · PubMed · Cited by 216
Pellagatti, A. (2006) · Blood · doi:10.1182/blood-2005-12-4769 · Cited by 209 · cited 1×
“considered as a framework to accommodate more reliable parameters in the future, such as flow cytometric immunophenotyping data(22,23) and, hopefully, molecular markers.(24) Cytogenetic pattern according to IPSS was proven to add prognostic information to the WHO subgroups.”
Alessandrino, E. P., Amadori, S., Barosi, G., Cazzola, M., Grossi, A., Liberato, L. N., Locatelli, F., Marchetti, M., Morra, E., Rebulla, P., et al. (2002) · PubMed · Cited by 178
Self-citationPredicting survival and leukemic evolution in patients with myelodysplastic syndrome.
Malcovati, L., Porta, M. G. D., & Cazzola, M. (2006) · PubMed · Cited by 161
Self-citationProspective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing, U., Strupp, C., Kuendgen, A., Isa, S., Knipp, S., Hildebrandt, B., Giagounidis, A. A. N., Aul, C., Gattermann, N., & Haas, R. R. (2006) · PubMed · Cited by 154
Self-citationThe WHO classification of MDS does make a difference
Howe, R. B., Porwit‐MacDonald, A., Wanat, R., Tehranchi, R., & Hellström-Lindberg, E. (2003) · Blood · doi:10.1182/blood-2003-06-2124 · Cited by 147
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome
Porta, M. G. D., Malcovati, L., Invernizzi, R., Travaglino, E., Pascutto, C., Maffioli, M., Gallì, A., Boggi, S., Pietra, D., Vanelli, L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404142 · Cited by 143
Self-citationDeschler-Baier, B., de Witte, T., Mertelsmann, R. H., & Lübbert, M. (2006) · PubMed · Cited by 138
Malcovati, L., Porta, M. G. D., Lunghi, M., Pascutto, C., Vanelli, L., Travaglino, E., Maffioli, M., BERNASCONI, P. P., Lazzarino, M., Invernizzi, R., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403680 · Cited by 125
Self-citationNösslinger, T., Reisner, R., Koller, E., Grüner, H., Tüchler, H., Nowotny, H., Pittermann, E., & Pfeilstöcker, M. (2001) · Blood · doi:10.1182/blood.v98.10.2935 · Cited by 119
Matsuda, A., Germing, U., Jinnai, I., Misumi, M., Kuendgen, A., Knipp, S., Aivado, M. A., Iwanaga, M., Miyazaki, Y., Tsushima, H., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0040 · Cited by 106
Self-citationMyelodysplastic Syndromes in Patients Younger Than Age 50
Kuendgen, A., Strupp, C., Aivado, M. A., Hildebrandt, B., Haas, R. R., Gattermann, N., & Germing, U. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5598 · Cited by 101
Self-citationPfeilstöcker, M., Reisner, R., Nösslinger, T., Grüner, H., Nowotny, H., Tüchler, H., Schlögl, E., Pittermann, E., & Heinz, R. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01559.x · Cited by 83
Morel, P., Declercq, C., Hebbar, M., Bauters, F., & Fenaux, P. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.6122056.x · Cited by 52
Cited by
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Solé, F., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2012) · Blood · doi:10.1182/blood-2012-03-420489 · Cited by 2,844
Self-citationClinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532
Tefferi, A., & Vardiman, J. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902908 · Cited by 670
Malcovati, L., Hellström-Lindberg, E., Bowen, D., Adès, L., Cermak, J., del Cañizo, C., Della Porta, M. G., Fenaux, P., Gattermann, N., Germing, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-492884 · Cited by 669
Self-citation
Metadata
- Authors
- Malcovati, L., Germing, U., Kuendgen, A., Della Porta, M. G., Pascutto, C., Invernizzi, R., Giagounidis, A., Hildebrandt, B., Bernasconi, P., Knipp, S., Strupp, C., Lazzarino, M., Aul, C., & Cazzola, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-08-10
- Volume
- 25
- Issue
- 23
- Pages
- 3503-3510
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2148968593
- Cited by
- 1,032
- References
- 26
- FWCI
- 45.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.